SARS-CoV, MERS-CoV, SARS-CoV-2 Comparison of Three Emerging Coronaviruses

Simple item page
AuthorAgnieszka Zeidleren
AuthorTomasz M. Karpinskien
OrcidAgnieszka Zeidler [0000-0003-0553-0441]en
OrcidTomasz M. Karpinski [0000-0001-6599-9204]en
Issued Date2020-06-30en
AbstractIn December 2019, in Wuhan, China began the outbreak of the new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) epidemic. As a result of rapid spread, it turned into a pandemic announced by WHO on March 11, 2020. SARS-CoV-2 is an etiological factor of a new disease called COVID-19. The virus is transmitted mainly through the droplet route. In most cases, it causes mild symptoms such as fever, dry cough, weakness, and muscle pain; less common symptoms include sore throat, runny nose, diarrhea, and chills. However, among people with impaired immunity and comorbidities, as well as among older people, it leads to life-threatening complications in the form of acute respiratory distress syndrome (ARDS), sepsis, and septic shock. Moreover, SARS-CoV-2 is the third highly pathogenic in humans and easily spreading coronavirus after the virus of a severe acute respiratory syndrome (SARS) in 2002 - 2003 and virus of the Middle East respiratory syndrome (MERS) in 2012. This review summarizes current information on the emergence, origin, diversity, and common characteristics, as well as the epidemiology of the above three highly contagious coronaviruses.en
DOIhttps://doi.org/10.5812/jjm.103744en
KeywordCoronavirusen
KeywordSARSen
KeywordMERS, SARS-CoV-2en
Keyword2019-nCoVen
KeywordCOVID-19en
KeywordPandemicen
KeywordPneumoniaen
PublisherBrieflandsen
TitleSARS-CoV, MERS-CoV, SARS-CoV-2 Comparison of Three Emerging Coronavirusesen
TypeReview Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
jjm-13-6-103744.pdf
Size:
963.69 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF
Download

Collections

Jundishapur Journal of Microbiology